| Seq |
Description |
Document |
Type |
Size |
| 1 |
ANNUAL REPORT |
f10k2017_relmadatherap.htm |
10-K |
1288745 |
| 2 |
CONSULTING AGREEMENT, DATED FEBRUARY 15, 2017, BETWEEN RELMADA THERAPEUTICS, INC |
f10k2017ex10-20_relmada.htm |
EX-10.20 |
63276 |
| 3 |
ASSIGNMENT AND CONSENT AGREEMENT, DATED JUNE 6, 2017, AMONG 275 MADISON AVENUE R |
f10k2017ex10-21_relmada.htm |
EX-10.21 |
30273 |
| 4 |
LEASE AGREEMENT, DATED MAY 2, 2017, BETWEEN RELMADA THERAPEUTICS, INC. AND REGUS |
f10k2017ex10-22_relmada.htm |
EX-10.22 |
30659 |
| 5 |
AMENDED AND RESTATED LICENSE AGREEMENT, DATED JUNE 8, 2017, BETWEEN ACTINIUM PHA |
f10k2017ex10-23_relmada.htm |
EX-10.23 |
20560 |
| 6 |
AGREEMENT, DATED JUNE 6, 2017, BETWEEN RELMADA THERAPEUTICS, INC. AND SANDESH SE |
f10k2017ex10-24_relmada.htm |
EX-10.24 |
92209 |
| 7 |
CONSULTING AGREEMENT, DATED JUNE 12, 2017, BETWEEN RELMADA THERAPEUTICS, INC. AN |
f10k2017ex10-25_relmada.htm |
EX-10.25 |
27966 |
| 8 |
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER, PURSUANT TO 18 U.S.C. SECTION 1350 |
f10k2017ex31-1_relmada.htm |
EX-31.1 |
10909 |
| 9 |
CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER, PURSUANT TO 18 U.S. |
f10k2017ex31-2_relmada.htm |
EX-31.2 |
10867 |
| 10 |
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER, PURSUANT TO 18 U.S.C. SECTION 1350 |
f10k2017ex32-1_relmada.htm |
EX-32.1 |
5897 |
| 11 |
CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER, PURSUANT TO 18 U.S. |
f10k2017ex32-2_relmada.htm |
EX-32.2 |
6046 |
| 18 |
GRAPHIC |
ex10-20_001.jpg |
GRAPHIC |
7054 |
| 19 |
GRAPHIC |
ex10-22_001.jpg |
GRAPHIC |
123589 |
| |
Complete submission text file |
0001213900-17-010097.txt |
|
5336539 |
